Market closed
GeneDx Holdings/$WGS
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About GeneDx Holdings
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
Ticker
$WGS
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
1,000
Website
GeneDx Holdings Metrics
BasicAdvanced
$2B
Market cap
-
P/E ratio
-$3.16
EPS
2.18
Beta
-
Dividend rate
Price and volume
Market cap
$2B
Beta
2.18
52-week high
$89.11
52-week low
$1.58
Average daily volume
617K
Financial strength
Current ratio
2.405
Quick ratio
2.003
Long term debt to equity
54.965
Total debt to equity
56.773
Interest coverage (TTM)
-16.50%
Management effectiveness
Return on assets (TTM)
-8.27%
Return on equity (TTM)
-36.40%
Valuation
Price to revenue (TTM)
7.301
Price to book
9.9
Price to tangible book (TTM)
47.78
Price to free cash flow (TTM)
-32.522
Growth
Revenue change (TTM)
29.41%
Earnings per share change (TTM)
-85.70%
3-year revenue growth (CAGR)
6.97%
3-year earnings per share growth (CAGR)
31.88%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for GeneDx Holdings stock?
GeneDx Holdings (WGS) has a market cap of $2B as of December 13, 2024.
What is the P/E ratio for GeneDx Holdings stock?
The price to earnings (P/E) ratio for GeneDx Holdings (WGS) stock is 0 as of December 13, 2024.
Does GeneDx Holdings stock pay dividends?
No, GeneDx Holdings (WGS) stock does not pay dividends to its shareholders as of December 13, 2024.
When is the next GeneDx Holdings dividend payment date?
GeneDx Holdings (WGS) stock does not pay dividends to its shareholders.
What is the beta indicator for GeneDx Holdings?
GeneDx Holdings (WGS) has a beta rating of 2.18. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.